Thermo Fisher Scientific, Inc. (TMO)
Thermo Fisher Scientific Market Cap : 259.33B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 259.15B |
| November 11, 2026 | 265.92B |
| November 10, 2026 | 266.10B |
| November 09, 2026 | 267.38B |
| November 06, 2026 | 257.42B |
| November 05, 2026 | 250.82B |
| November 04, 2026 | 261.64B |
| November 03, 2026 | 258.75B |
| November 02, 2026 | 252.93B |
| October 30, 2026 | 258.25B |
| October 29, 2026 | 262.76B |
| October 28, 2026 | 260.90B |
| October 27, 2026 | 256.77B |
| October 26, 2026 | 253.24B |
| October 23, 2026 | 249.14B |
| October 22, 2026 | 250.15B |
| October 21, 2026 | 256.61B |
| October 20, 2026 | 254.15B |
| October 19, 2026 | 251.20B |
| October 16, 2026 | 255.13B |
| October 15, 2026 | 257.53B |
| October 14, 2026 | 248.91B |
| October 13, 2026 | 245.16B |
| October 12, 2026 | 244.86B |
| October 09, 2026 | 243.30B |
| Date | Value |
|---|---|
| October 08, 2026 | 241.07B |
| October 07, 2026 | 244.79B |
| October 06, 2026 | 242.77B |
| October 05, 2026 | 250.23B |
| October 02, 2026 | 242.11B |
| October 01, 2026 | 241.26B |
| September 30, 2026 | 249.60B |
| September 29, 2026 | 251.28B |
| September 28, 2026 | 250.91B |
| September 25, 2026 | 249.58B |
| September 24, 2026 | 250.83B |
| September 23, 2026 | 245.99B |
| September 22, 2026 | 243.49B |
| September 21, 2026 | 243.57B |
| September 18, 2026 | 240.87B |
| September 17, 2026 | 243.41B |
| September 16, 2026 | 239.76B |
| September 15, 2026 | 237.15B |
| September 14, 2026 | 226.88B |
| September 11, 2026 | 225.48B |
| September 10, 2026 | 223.02B |
| September 09, 2026 | 223.95B |
| September 08, 2026 | 222.97B |
| September 04, 2026 | 226.94B |
| September 03, 2026 | 228.66B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Agilent Technologies, Inc. | 49.06B |
| Bio-Rad Laboratories, Inc. | 9.842B |
| Danaher Corp. | 163.93B |
| Illumina, Inc. | 31.47B |
| Revvity, Inc. | 17.24B |
Market Cap Related Metrics
| PE Ratio | 36.93 |
| PS Ratio | 5.513 |
| PEG Ratio | 3.881 |
| Price to Book Value | 4.736 |
| Price to Free Cash Flow | 34.37 |
| Price | 699.92 |
| Earnings Yield | 2.71% |
| PEGY Ratio | 3.777 |
| Operating PE Ratio | 28.85 |
| Normalized PE Ratio | 36.29 |